Cargando…

Isoniazid Preventive Therapy and Risk for Resistant Tuberculosis

In the context of tuberculosis (TB) resurgence, isoniazid preventive therapy (IPT) is increasingly promoted, but concerns about the risk for development of isoniazid-resistant tuberculosis may hinder its widespread implementation. We conducted a systematic review of data published since 1951 to asse...

Descripción completa

Detalles Bibliográficos
Autores principales:	Balcells, Maria Elvira, Thomas, Sara L., Godfrey-Faussett, Peter, Grant, Alison D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Centers for Disease Control and Prevention 2006
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3374455/ https://www.ncbi.nlm.nih.gov/pubmed/16704830 http://dx.doi.org/10.3201/eid1205.050681

Ejemplares similares

A community-based isoniazid preventive therapy for the prevention of childhood tuberculosis in Ethiopia
por: Datiko, D. G., et al.
Publicado: (2017)

Eligibility for Isoniazid Preventive Therapy in South African Gold Mines
por: Lewis, James J., et al.
Publicado: (2013)

The timing of tuberculosis after isoniazid preventive therapy among gold miners in South Africa: a prospective cohort study
por: Hermans, Sabine M., et al.
Publicado: (2016)

Treatment of isoniazid-resistant pulmonary tuberculosis
por: Kim, Yee Hyung, et al.
Publicado: (2008)

Treatment of Isoniazid-Resistant Pulmonary Tuberculosis
por: Jhun, Byung Woo, et al.
Publicado: (2020)

Impact of Isoniazid Resistance-Conferring Mutations on the Clinical Presentation of Isoniazid Monoresistant Tuberculosis
por: Dantes, Raymund, et al.
Publicado: (2012)

Tuberculosis Control in South African Gold Mines: Mathematical Modeling of a Trial of Community-Wide Isoniazid Preventive Therapy
por: Vynnycky, Emilia, et al.
Publicado: (2015)

Isoniazid for preventing tuberculosis in HIV‐infected children
por: Zunza, Moleen, et al.
Publicado: (2017)

Risk of Disease After Isoniazid Preventive Therapy for Mycobacterium tuberculosis Exposure in Young HIV-uninfected Children
por: Luabeya, Kany Kany A., et al.
Publicado: (2015)

Isoniazid-Resistant Tuberculosis, Taiwan, 2000–2010
por: Lai, Chih-Cheng, et al.
Publicado: (2011)

Efficacy of isoniazid prophylactic therapy in prevention of tuberculosis in children: a meta–analysis
por: Ayieko, James, et al.
Publicado: (2014)

Minimum inhibitory concentrations of rifampin and isoniazid among multidrug and isoniazid resistant Mycobacterium tuberculosis in Ethiopia
por: Getahun, Muluwork, et al.
Publicado: (2022)

Pellagra in isoniazid preventive and antiretroviral therapy
por: Kipsang, John Koech, et al.
Publicado: (2019)

Hyperglycaemia induced by isoniazid preventive therapy
por: Ganguly, Roshni Jhan, et al.
Publicado: (2018)

Risk factors for infection and disease in child contacts of multidrug-resistant tuberculosis: a cross-sectional study
por: Seddon, James A, et al.
Publicado: (2013)

Impact of Bacterial Genetics on the Transmission of Isoniazid-Resistant Mycobacterium tuberculosis
por: Gagneux, Sebastien, et al.
Publicado: (2006)

Emergence and selection of isoniazid and rifampin resistance in tuberculosis granulomas
por: Pienaar, Elsje, et al.
Publicado: (2018)

Response to Isoniazid-Resistant Tuberculosis in Homeless Shelters, Georgia, USA, 2015–2017
por: Holland, David P., et al.
Publicado: (2019)

Prevention of isoniazid toxicity by NAT2 genotyping in Senegalese tuberculosis patients
por: Toure, A., et al.
Publicado: (2016)

Safety and tolerability of isoniazid preventive therapy for tuberculosis for persons with HIV with and without alcohol use
por: Hahn, Judith A., et al.
Publicado: (2023)

HIV treatment cascade in tuberculosis patients
por: Lessells, Richard J., et al.
Publicado: (2015)

Fluoroquinolones and isoniazid-resistant tuberculosis: implications for the 2018 WHO guidance
por: Stagg, Helen R., et al.
Publicado: (2019)

Effectiveness of isoniazid preventive therapy on incidence of tuberculosis among HIV-infected adults in programme setting
por: Padmapriyadarsini, C., et al.
Publicado: (2020)

Effect of isoniazid preventive therapy on immune responses to mycobacterium tuberculosis: an open label randomised, controlled, exploratory study
por: Biraro, Irene Andia, et al.
Publicado: (2015)

Beneficial Effect of Isoniazid Preventive Therapy and Antiretroviral Therapy on the Incidence of Tuberculosis in People Living with HIV in Ethiopia
por: Yirdaw, Kesetebirhan Delele, et al.
Publicado: (2014)

The molecular basis of resistance to isoniazid, rifampin, and pyrazinamide in Mycobacterium tuberculosis
por: Somoskovi, Akos, et al.
Publicado: (2001)

Quantifying the Burden and Trends of Isoniazid Resistant Tuberculosis, 1994–2009
por: Jenkins, Helen E., et al.
Publicado: (2011)

Contribution of Efflux to the Emergence of Isoniazid and Multidrug Resistance in Mycobacterium tuberculosis
por: Machado, Diana, et al.
Publicado: (2012)

Isoniazid resistance without a loss of fitness in Mycobacterium tuberculosis
por: Lee, Jong-Hee, et al.
Publicado: (2012)

Adverse effects of isoniazid preventative therapy for latent tuberculosis infection: a prospective cohort study
por: Denholm, Justin T, et al.
Publicado: (2014)

Effect of isoniazid preventive therapy on tuberculosis or death in persons with HIV: a retrospective cohort study
por: Ayele, Henok Tadesse, et al.
Publicado: (2015)

Bacterial risk factors for treatment failure and relapse among patients with isoniazid resistant tuberculosis
por: Thai, Phan Vuong Khac, et al.
Publicado: (2018)

Xpert MTB/XDR for detection of pulmonary tuberculosis and resistance to isoniazid, fluoroquinolones, ethionamide, and amikacin
por: Pillay, Samantha, et al.
Publicado: (2022)

In silico analyses of isoniazid and streptomycin resistance-associated mutations in Mycobacterium tuberculosis
por: Dasoondi, Rushikesh Singh, et al.
Publicado: (2023)

Detecting Novel Genetic Variants Associated with Isoniazid-Resistant Mycobacterium tuberculosis
por: Shekar, Sandhya, et al.
Publicado: (2014)

Isoniazid prophylaxis: highly effective but underutilised to prevent tuberculosis in people living with HIV
por: Vojnov, Lara, et al.
Publicado: (2022)

Isoniazid preventive therapy: Uptake, incidence of tuberculosis and survival among people living with HIV in Bulawayo, Zimbabwe
por: Nyathi, Saziso, et al.
Publicado: (2019)

Incidence of tuberculosis among PLHIV on antiretroviral therapy who initiated isoniazid preventive therapy: A multi-center retrospective cohort study
por: Kazibwe, Andrew, et al.
Publicado: (2022)

Adherence with isoniazid for prevention of tuberculosis among HIV-infected adults in South Africa
por: Szakacs, Tom A, et al.
Publicado: (2006)

Design, Synthesis, and Evaluation of Novel Δ(2)-Thiazolino 2-Pyridone Derivatives That Potentiate Isoniazid Activity in an Isoniazid-Resistant Mycobacterium tuberculosis Mutant
por: Sarkar, Souvik, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_qobvt4qodti7csqndljos3enuf